These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6619893)

  • 21. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experiences with desmopressin for long-term treatment of nocturia.
    Lose G; Mattiasson A; Walter S; Lalos O; van Kerrebroeck P; Abrams P; Freeman R
    J Urol; 2004 Sep; 172(3):1021-5. PubMed ID: 15311028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis.
    Weatherall M
    Neurourol Urodyn; 2004; 23(4):302-5. PubMed ID: 15227644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG; Lavery HJ; Wu DL
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyponatremia in elderly patients treated with desmopressin for nocturia: a review of a case series.
    Callréus T; Ekman E; Andersen M
    Eur J Clin Pharmacol; 2005 Jun; 61(4):281-4. PubMed ID: 15875172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmopressin in nocturnal enuresis.
    Aladjem M; Wohl R; Boichis H; Orda S; Lotan D; Freedman S
    Arch Dis Child; 1982 Feb; 57(2):137-40. PubMed ID: 7039520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
    Asplund R; Sundberg B; Bengtsson P
    BJU Int; 1999 Apr; 83(6):591-5. PubMed ID: 10233563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta-analysis.
    Hajebrahimi S; Darvishi A; HajEbrahimi R; Asadi N; Jafari Shendi Z; Asiaban N; Naseri A; Sadeghi-Ghyassi F; Mostafaei H; Salehi-Pourmehr H
    Neurourol Urodyn; 2024 Jan; 43(1):167-182. PubMed ID: 37746880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desmopressin for nocturia in adults.
    Drug Ther Bull; 2017 Mar; 55(3):30-32. PubMed ID: 28279978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns.
    Rembratt A; Norgaard JP; Andersson KE
    BJU Int; 2003 May; 91(7):642-6. PubMed ID: 12699476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of desmopressin in the treatment of adult nocturia.
    Abrams P; Mattiasson A; Lose GR; Robertson GL
    BJU Int; 2002 Dec; 90 Suppl 3():32-6. PubMed ID: 12445098
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of nocturnal enuresis with a vasopressin analogue.
    Terho P; Kekomäki M
    J Urol; 1984 May; 131(5):925-7. PubMed ID: 6368874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.
    Mizuno H; Fujimoto S; Sugiyama Y; Kobayashi M; Ohro Y; Uchida S; Sasaki S; Togari H
    Horm Res; 2003; 59(6):297-300. PubMed ID: 12784095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DDAVP, a synthetic analogue of vasopressin, in prevention of headache after lumbar puncture and lumbar pneumoencephalography.
    Hansen PE; Hansen JH
    Acta Neurol Scand; 1979 Sep; 60(3):183-8. PubMed ID: 517118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of DDAVP (desmopressin) in primary nocturnal enuresis].
    Bernasconi S; Monti G
    Minerva Pediatr; 1982 Feb; 34(3):131-4. PubMed ID: 7078535
    [No Abstract]   [Full Text] [Related]  

  • 38. Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis.
    Fredrikson S
    Acta Neurol Scand; 1996 Jul; 94(1):31-4. PubMed ID: 8874590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmopressin in the management of nocturnal enuresis in children: a double-blind study.
    Birkásová M; Birkás O; Flynn MJ; Cort JH
    Pediatrics; 1978 Dec; 62(6):970-4. PubMed ID: 366538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES; Raymond K; Andruczyk E; Juul KV
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.